Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03546894
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2018-05-23
Brief Title:
A Study to Determine Progression-free Survival PFS and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive ALK Non-Small Cell Lung Cancer NSCLC Treated With Anaplastic Lymphoma Kinase ALK Inhibitors
Sponsor:
Takeda
Organization:
Takeda
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-23
First Submit QC Date:
May 23 2018
Study First Post Date:
2018-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-11
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED